Vaccine Adherence in Risk Group Obese Individuals

Öz

Objective: Vaccine studies have gained importance along with the COVID-19 epidemic. With the start of vaccination practices, an increasing number of cases showing refusal or hesitation of vaccines have been observed. Our aim in this article is to determine whether there is vaccine refusal or hesitation among HIV-infected individuals and to reveal the reasons for this. Material and Methods: In this descriptive study, a survey was administered to 65 participants who applied to the HIV outpatient clinics in June, July and August 2021. Information about the patients' medical history and information about their current medical conditions was obtained, and the reasons for COVID-19 vaccine hesitancy were learned. A persuasive method called “anticipated regret” has been used to persuade patients to get vaccinated. Results: Forty obese people living with HIV (PLWH) were included in the study. 22.5% (n=9) of PLWH were female, 77.5% (n=31) were male, and the median age was 36.5 years (mean 39.7±11.6 years; min-max: 22-62 years). Vaccination rate in females was found significantly lower than in males (p=0.006). According to sexual orientation, the vaccination rate was significantly higher among men who have sex with men (MSM) (p=0.002). It was determined that 30% (n=12) of the patients did not receive the COVID-19 vaccine, and all of them had the intention of receiving the vaccine. When the reasons why patients did not receive the COVID-19 vaccine were examined, the first reason was that the vaccines were unsafe with a rate of 66.6% (n = 8). Conclusion: In this study, we found that the vaccination rate of people living with HIV is higher than the vaccination rate of the general population. It is thought that the reason for the higher vaccination rate in people living with HIV is due to the fact that medical counseling is provided at every follow-up.

Anahtar Kelimeler

• COVID-19
• vaccine
• HIV

RİSK GRUBU OLAN OBEZ BİREYLERDE AŞI UYUMU

Öz

Amaç: COVID-19 pandemisi ile birlikte aşı çalışmaları da önem kazanmış durumdadır. Aşı uygulamalarının başlamasıyla aşı karşıtlığı veya tereddütü gösteren vakaların da arttığı görülmektedir. Bu çalışmada amacımız HIV ile enfekte bireylerde aşı karşıtlığı veya tereddütü olup olmadığını belirleyerek bunun sebeplerini açığa çıkarmaktır. Gereç ve Yöntemler: Bu tanımlayıcı çalışmada, 2021 yılı Haziran, Temmuz, Ağustos aylarında HIV polikliniğine başvuran 65 katılımcıya anket uygulanmıştır. Hastaların tıbbi geçmişlerine ait bilgiler ve mevcut tıbbi durumları hakkında bazı bilgiler alınmış ve beraberinde COVID-19 aşı tereddütlerinin nedenleri öğrenilmiştir. Hastaları aşı yaptırmaya ikna etmek için “beklenen pişmanlık” denilen ikna edici bir yöntem uygulanmıştır. Bulgular: Araştırmaya 40 HIV ile yaşayan obez birey (HYB) dâhil edilmiştir. Bireylerin %22,5’i (n=9) kadın, %77,5’i (n=31) erkek olup yaş medyanı 36,5 yıldır (ortalama 39,7±11,6 yıl; min-maks:22-62 yıl). Kadınlarda aşılanma oranı erkeklere göre anlamlı şekilde düşük bulunmuştur (p=0,006). Cinsel yönelime göre erkeklerle seks yapan erkeklerde (MSM) aşılanma oranı anlamlı şekilde daha yüksektir (p=0,002). Hastaların %30’unun (n=12) COVID-19 aşısı yaptırmadığı tespit edilmiştir ve tümünün aşı yaptırma niyeti mevcuttur. Hastaların COVID-19 aşısı yaptırmama nedenleri incelendiğinde ilk sırayı %66,6’lık (n=8) bir oran ile aşıların güvensiz olması almıştır. Sonuç: Bu çalışmamızda, HIV ile yaşayan bireylerde aşılama oranının toplumun aşılanma oranına göre daha yüksek olduğunu tespit ettik. HIV ile yaşayan bireylerdeki aşılanma oranının daha yüksek olma nedeninin her takipte tıbbi danışmanlık veriliyor olmasından kaynaklandığı düşünülmüştür.

Anahtar Kelimeler

• COVID-19
• aşı
• HIV

Kaynakça

1. McLachlan S, & NCD Risk Factor Collaboration. Trends in adult body mass index in 200 countries since 1975: pooled analysis of 1,698 population-based measurement studies with 19.2 million participants. The Lancet, 2016;387:10026.
2. Piché ME, Tchernof A, Després JP. Obesity phenotypes, diabetes, and cardiovascular diseases. Circulation research. 2020;126(11):1477-1500.
3. Cuschieri S, Grech S. Obesity population at risk of COVID-19 complications. Glob Health Epidemiol Genom .2020;5;e6.
4. Mahase E. Covid-19: WHO declares pandemic because of “alarming levels” of spread, severity, and inaction. BMJ .2020;368:m1036.
5. Zhou Y, Chi J, Lv W, Wang Y. Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19). Diabetes Metab Res Rev. 2021;37(2):e3377.
6. Ejaz H, Alsrhani A, Zafar A, et al. COVID-19 and comorbidities: Deleterious impact on infected patients. J Infect Public Health. 2020;13(12):1833-1839.
7. Kutlu HH ,Altındiş M. Aşı karşıtlığı. FLORA. 2018;23(2):47-58.
8. Lopez Bernal J, Andrews N, Gower C, et al. .Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study. BMJ. 2021;373:n1088.

9. Jacobson RM, St. Sauver JL, Finney Rutten LJ. Vaccine hesitancy. Mayo Clin Proc. 2015;90(11):1562-1568.
10. Lin C, Tu P, Beitsch L.M. Confidence and receptivity for COVID-19 vaccines: A rapid systematic review. Vaccines. 2020;9:16.
11. Sallam M. COVID-19 vaccine hesitancy worldwide: A concise systematic review of vaccine acceptance rates. Vaccines (Basel). 2021;9(2):160.
12. Bogart LM, Ransome Y, Allen W, Higgins-Biddle M, Ojikutu BO. HIV-related medical mistrust, HIV testing, and HIV risk in the National Survey on HIV in the Black community. Behav Med. 2019;45:134-142.
13. Gür E. Aşı kararsızlığı-aşı reddi. Turk Pediatri Ars. 2019; 54(1):1-2.
14. Yiğit T, Oktay BÖ, Özdemir CN, Moustafa Pasa S. Aşı karşıtlığı ve fikri gelişimi. Uluslararası Sosyal ve Beşeri Bilimler Araştırma Dergisi. 2020;7(53):1244-1261.
15. Sigel K, Swartz T, Golden E, et al. Coronavirus2019 and People Living with Human Immunodeficiency Virus: Outcomes for Hospitalized Patients in New York City. Clin. Infect.Dis. Off. Publ. Infect. Dis. Soc. Am. 2020;71:2933-2938.
16. Keys A, Fidanza F, Karvonen MJ, Kimura N, Taylor HL. Indices of relative weight and obesity. Journal of chronic diseases. 1972; 25(6-7): 329-343.
17. T.C. Sağlık Bakanlığı, COVID-19 Aşısı, Bilgilendirme Platformu. Erişim tarihi: 30 Ağustos 2021: https://covid19asi.saglik.gov.tr/
18. Bogart LM, Ojikutu BO, Tyagi K, et al. COVID-19 Related Medical Mistrust, Health Impacts, and Potential Vaccine Hesitancy Among Black Americans Living With HIV. J Acquir Immune Defic Syndr. 2021;86(2):200-207.
19. Vallée A, Fourn E, Majerholc C, Touche P, Zucman D. COVID-19 vaccine hesitancy among french people living with HIV. Vaccines (Basel). 2021;9(4):302.
20. Bongomin F, Olum R, Andia-Biraro I, et al. COVID-19 vaccine acceptance among high-risk populations in Uganda.Ther Adv Infect Dis. 2021;8:1-15.
21. Lazarus JV, Ratzan SC, Palayew A, et al. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021;27:225-228.
22. Alqudeimat Y, Alenezi D, AlHajri B, et al. Acceptance of a COVID-19 vaccine and its related determinants among the general adult population in Kuwait. Med Princ Pract. 2021;10:2052-2061.
23. Kourkounti S, Paparizos V, Leuow K, Paparizou E, Antoniou C. Adherence to hepatitis A virus vaccination in HIV-infected men who have sex with men. Int J STD AIDS. 2015;26(12):852-856.
24. Tedaldi EM, Baker RK, Moorman AC, et al. Hepatitis A and B vaccination practices for ambu-latory patients infected with HIV. Clin Infect Dis. 2004;38(10):1478-1484.
25. Tsachouridou O, Georgiou A, Naoum S, et al. Factors associated with poor adherence to vaccination against hepatitis viruses, streptococcus pneumoniae and seasonal influenza in HIV-infected adults. Hum Vaccin Immunother. 2019;15(2):295-304.
26. Ruijs WLM, Hautvast JLA, Van Ansem WJC, et al. Measuring vaccination coverage in a hard to reach minority. Eur J Public Health. 2012;22(3):359-364.
27. Kilic M, Ustundag Ocal N, Uslukilic G. The relationship of Covid-19 vaccine attitude with life satisfaction, religious attitude and Covid-19 avoidance in Turkey. Hum Vaccin Immunother. 2021;17(10):3384-3393.
28. Jacobi CJ, Vaidyanathan B. Racial differences in anticipated COVID-19 vaccine acceptance among religious populations in the US. Vaccine. 2021;39(43):6351-6355.
29. Syed Alwi SAR, Rafidah E, Zurraini A, Juslina O, Brohi IB, Lukas S. A survey on COVID-19 vaccine acceptance and concern among Malaysians. BMC Public Health. 2021;21(1):1129.
30. Rasmussen SA, Kelley CF, Horton JP, Jamieson DJ. Coronavirus Disease 2019 (COVID-19) Vaccines and pregnancy: What obstetricians need to know. Obstet Gynecol. 2021;137(3):408-414.